Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPH.L Regulatory News (DPH)

  • There is currently no data for DPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BLOCK LISTING SIX MONTHLY RETURN

15 Sep 2017 14:00

RNS Number : 9199Q
Dechra Pharmaceuticals PLC
15 September 2017
 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 15 September 2017

 

Name of applicant:

Dechra Pharmaceuticals PLC

Name of scheme:

Long-Term Incentive Scheme

Period of return:

From:

15 March 2017

To:

14 September 2017

Balance of unallotted securities under scheme(s) from previous return:

21,507

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

174,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

Nil

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

195,507

 

 

 

Name of contact:

Melanie Hall

Telephone number of contact:

01606 814730

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 15 September 2017

 

Name of applicant:

Dechra Pharmaceuticals PLC

Name of scheme:

Approved Share Option Scheme

Period of return:

From:

15 March 2017

To:

14 September 2017

Balance of unallotted securities under scheme(s) from previous return:

8,184

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

25,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

6,077

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

27,107

 

 

 

Name of contact:

Melanie Hall

Telephone number of contact:

01606 814 730

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 15 September 2017

 

Name of applicant:

Dechra Pharmaceuticals PLC

Name of scheme:

Unapproved Share Option Scheme

Period of return:

From:

15 March 2017

To:

14 September 2017

Balance of unallotted securities under scheme(s) from previous return:

65,972

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

55,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

23,254

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

97,718

 

 

 

Name of contact:

Melanie Hall

Telephone number of contact:

01606 814 730

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 15 September 2017

 

Name of applicant:

Dechra Pharmaceuticals PLC

Name of scheme:

SAYE Scheme

Period of return:

From:

15 March 2017

To:

14 September 2017

Balance of unallotted securities under scheme(s) from previous return:

11,811

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

75,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

70,378

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

16,433

 

 

 

Name of contact:

Melanie Hall

Telephone number of contact:

01606 814 730

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRGGUQABUPMGPA
Date   Source Headline
28th Dec 20233:20 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
28th Dec 20232:10 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
28th Dec 20231:20 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
28th Dec 20231:06 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
28th Dec 202312:35 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
28th Dec 202310:16 amRNSForm 8.5 (EPT/RI)
28th Dec 202310:11 amRNSForm 8.5 (EPT/NON-RI)
28th Dec 20239:55 amRNSForm 8.5 (EPT/RI)- Dechra Pharmaceuticals plc
28th Dec 20239:40 amRNSForm 8.3 - Dechra Pharmaceuticals plc
28th Dec 20239:27 amRNSForm 8.3 - Dechra Pharmaceuticals plc
28th Dec 20237:15 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
27th Dec 20233:30 pmRNSForm 8.3 - DPH LN
27th Dec 20233:30 pmGNWForm 8.3 - Dechra Pharmaceuticals plc
27th Dec 20232:28 pmRNSHolding(s) in Company
27th Dec 20232:27 pmRNSHolding(s) in Company
27th Dec 20231:46 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
27th Dec 202312:59 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
27th Dec 202312:34 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
27th Dec 202312:16 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
27th Dec 20239:55 amRNSForm 8.3 - Dechra Pharmaceuticals PLC
27th Dec 20239:38 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
27th Dec 20238:29 amGNWForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc
27th Dec 20237:30 amRNSForm 8.3 - Dechra Pharmaceuticals plc
27th Dec 20237:00 amRNSForm 8.5 (EPT/RI)
27th Dec 20237:00 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
27th Dec 20237:00 amRNSForm 8.5 (EPT/RI)-Replacement of Dechra
27th Dec 20237:00 amRNSUpdate on Conditions
27th Dec 20237:00 amRNSForm 8.3 - Dechra Pharmaceuticals plc
27th Dec 20237:00 amRNSForm 8.3 - Dechra Pharmaceuticals plc
26th Dec 20231:54 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
22nd Dec 20232:27 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
22nd Dec 20231:45 pmPRNForm 8.3 - Dechra Pharmaceuticals PLC
22nd Dec 20231:06 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
22nd Dec 20231:00 pmRNSForm 8.3 - Dechra Pharmaceuticals Plc
22nd Dec 202311:57 amRNSForm 8.3 - Dechra Pharmaceuticals plc
22nd Dec 202311:42 amRNSForm 8.3 - Dechra Pharmaceuticals plc
22nd Dec 202311:03 amGNWForm 8.3 - Dechra Pharmaceuticals PLC
22nd Dec 202310:33 amRNSForm 8.5 (EPT/RI)-Replacement of Dechra
22nd Dec 202310:23 amRNSForm 8.5 (EPT/RI)
22nd Dec 202310:20 amRNSForm 8.5 (EPT/NON-RI)
22nd Dec 202310:19 amRNSForm 8.5 (EPT/NON-RI) - Dechra Pharmaceuticals Plc
22nd Dec 20239:46 amRNSForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc
22nd Dec 20238:50 amRNSForm 8.3 - Dechra Pharmaceuticals plc
21st Dec 20233:25 pmRNSForm 8.3 - Dechra Pharmaceuticals Plc
21st Dec 20233:25 pmRNSForm 8.3 - Dechra Pharmaceuticals PLC
21st Dec 20233:20 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
21st Dec 20233:04 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
21st Dec 20232:34 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
21st Dec 20232:16 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals PLC
21st Dec 20231:40 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.